GoodRx Holdings, Inc. (GDRX)

NasdaqGS • Currently down 0.10 (-3.31%) in today's trading session

1 member of Congress has disclosed 1 trade in GoodRx Holdings, Inc. (GDRX) via STOCK Act filings. The most recent disclosure was a purchase by Anthony Gonzalez on 25 March 2021. Aggregate disclosed activity totals roughly $175K in purchases (midpoint estimates from bracketed disclosure amounts).

GoodRx Holdings, Inc. is currently trading at $2.92, positioned at 54% of its 52-week range ($1.77 – $3.89).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$2.92
24h Change
-0.10 (-3.31%)
52 Week Range
$1.77–$3.89
View on NASDAQ

GoodRx Holdings, Inc. Price History and Technical Analysis

Congressional Trading Activity for GDRX

Select to highlight on chart
1 transactions
Compliance: 100%
Anthony Gonzalez25 Mar 202123 Apr 2021PurchaseStock$100,001 - $250,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$996.14M

Volume

2.01M

Beta

1.67

P/E Ratio

9.13

Fundamentals

EPS

$0.32

Div. Yield

-

Open

$2.99

Day Range

$2.91 – $3.09

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ · USD
Country
US
CEO
Wendy Barnes
IPO Date
2020-09-23

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customi...

Earnings

Next Report

Q3 2026

23 Nov

EPS Est.

$0.07

Rev. Est.

$203.3M

Days Until

1

Recent Quarters

Q3 202620 Nov
EPS-
Q3 202618 Nov
EPS-
Q3 202617 Nov
EPS-
Q3 202613 Nov
EPS-
Q3 202611 Nov
EPS-
Q3 202610 Nov
EPS-
Q3 20269 Nov
EPS-
Q3 20263 Nov
EPS-
Q2 20265 Aug
EPS$0.08
Beat 0.4%
Q1 20266 May
EPS$0.07
Beat 0.0%
Q4 202525 Feb
EPS$0.09
Beat 0.0%
Q3 20254 Nov
EPS$0.08
Miss 11.1%
Q2 20256 Aug
EPS$0.09
Miss 10.0%
Q1 20257 May
EPS$0.09
Beat 0.0%
Q4 202427 Feb
EPS$0.09
Miss 10.0%
Q3 20247 Nov
EPS$0.08
Miss 11.1%
Q2 20248 Aug
EPS$0.08
Miss 11.1%
Q1 20249 May
EPS$0.08
Miss 11.1%
Q4 202329 Feb
EPS$0.08
Beat 0.0%
Q3 20239 Nov
EPS$0.06
Beat 0.0%
Q2 20239 Aug
EPS$0.07
Beat 16.7%
Q1 202310 May
EPS$0.07
Beat 16.7%
Q4 202228 Feb
EPS$0.07
Beat 40.0%
Q3 20228 Nov
EPS$0.07
Beat 72.6%
Q2 20228 Aug
EPS$0.06
Beat 54.4%
Q1 20229 May
EPS$0.10
Beat 25.0%
Q4 202128 Feb
EPS$0.09
Miss 10.0%
Q3 202110 Nov
EPS$0.09
Beat 12.5%
Q2 202112 Aug
EPS$0.08
Beat 0.0%
Q1 202113 May
EPS$0.07
Miss 12.5%
Q4 202011 Mar
EPS$0.08
Beat 33.3%
Q3 202012 Nov
EPS$0.09
Beat 12.5%
Q2 202010 Aug
EPS$0.07
Q2 20202 Jul
EPS$0.08
Q3 201931 Dec
EPS$0.04
Q2 201930 Sept
EPS$0.05
Q1 201930 Jun
EPS$0.09
Q4 201831 Mar
EPS$0.04

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

FWONK

Formula One Group

17
$103.64-2.77 (-2.60%)
Communication Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about GDRX

Which members of Congress have traded GDRX?
1 member of Congress has disclosed 1 trade in GoodRx Holdings, Inc. (GDRX) under the STOCK Act: Anthony Gonzalez.
When was GDRX most recently disclosed by Congress?
The most recent GDRX disclosure was a purchase by Anthony Gonzalez on 25 March 2021.
What is the total disclosed congressional trading volume for GDRX?
Members of Congress have disclosed approximately $175K in GDRX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in GDRX?
This GDRX page updates as soon as new STOCK Act disclosures are filed for GoodRx Holdings, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.